InVivo Therapeutics Corporation Reports 2014 Second Quarter Financial Results and Business Update

free biotech news Get the latest biotech news where you want it. Sign up for the 

free GenePool newsletter today!

InVivo Therapeutics Holdings Corp. (NVIV) today reported financial results for the quarter ended June 30, 2014.

Mark Perrin, the CEO of InVivo, said, “Given the accomplishments of the first half year, I am tremendously excited that as we enter the second half of 2014, we will be able to successfully leverage and build on the major strengths and capabilities that have been established.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC